Analyst Price Targets — SLP
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 18, 2026 11:16 am | — | Craig-Hallum | $18.50 | $18.25 | TheFly | Simulations Plus downgraded to Hold from Buy at Craig-Hallum |
| July 29, 2024 2:05 am | Scott Schoenhaus | KeyBanc | $47.00 | $39.70 | StreetInsider | KeyBanc Starts Simulations Plus (SLP) at Overweight |
| June 13, 2024 8:55 am | Matt Hewitt | Craig-Hallum | $56.00 | $49.60 | TheFly | Simulations Plus price target raised to $56 from $51 at Craig-Hallum |
| June 13, 2024 6:24 am | Francois Brisebois | Oppenheimer | $65.00 | $49.26 | StreetInsider | Simulations Plus (SLP) PT Raised to $65 at Oppenheimer |
| June 21, 2023 2:56 pm | Francois Brisebois | Oppenheimer | $67.00 | $48.07 | Benzinga | Simulations Plus Is High-Growth Investment Opportunity In The Wake Of Immunetrics Acquisition: Analyst |
Latest News for SLP
SAN DIEGO, July 13, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) on behalf of investors who suffered losses and whether those losses may be recoverable under federal securities laws.
SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--PULM, SLP, OLN, and HUN PR Newswire
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today reported financial results for its third quarter fiscal 2026, ended May 31, 2026. Third Quarter 2026 Financial Highlights (as compared to third quarter 2025) Total revenue increased 7%…
SAN DIEGO, July 08, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) on behalf of investors who suffered losses and whether those losses may be recoverable under federal securities laws.
SAN DIEGO, July 6, 2026 /PRNewswire/ -- Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) on behalf of investors who suffered losses and whether those losses may be recoverable under federal securities laws. On April 3, 2025, Simulations Plus reported second-quarter fiscal 2025 financial results and maintained full-year revenue guidance of $90 million to $93 million.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for SLP.
U.S. House Trading
No House trades found for SLP.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.